Haleon PLC Sponsored ADR (NYSE:HLN) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Haleon PLC Sponsored ADR (NYSE:HLN) has earned a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold rating, four have issued a buy rating and two have given a strong buy rating to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $12.33.

A number of equities analysts have recently weighed in on the stock. Barclays reissued an “overweight” rating on shares of Haleon in a research report on Tuesday, May 6th. BNP Paribas Exane raised shares of Haleon from a “neutral” rating to an “outperform” rating and set a $13.40 price objective for the company in a research report on Tuesday, May 27th. Wall Street Zen raised shares of Haleon from a “hold” rating to a “buy” rating in a research report on Friday, June 6th. BNP Paribas raised shares of Haleon to a “strong-buy” rating in a research report on Tuesday, May 27th. Finally, Morgan Stanley raised shares of Haleon from an “equal weight” rating to an “overweight” rating and set a $11.25 price objective for the company in a research report on Friday, May 9th.

Institutional Investors Weigh In On Haleon

A number of institutional investors have recently bought and sold shares of HLN. Brighton Jones LLC purchased a new stake in Haleon in the fourth quarter valued at approximately $187,000. Bank of New York Mellon Corp grew its holdings in Haleon by 29.8% in the fourth quarter. Bank of New York Mellon Corp now owns 2,071,017 shares of the company’s stock valued at $19,758,000 after purchasing an additional 475,934 shares during the period. SVB Wealth LLC purchased a new stake in Haleon in the fourth quarter valued at approximately $121,000. Jones Financial Companies Lllp grew its holdings in Haleon by 57.2% in the fourth quarter. Jones Financial Companies Lllp now owns 162,187 shares of the company’s stock valued at $1,547,000 after purchasing an additional 59,006 shares during the period. Finally, Steward Partners Investment Advisory LLC grew its holdings in Haleon by 198.6% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 45,523 shares of the company’s stock valued at $434,000 after purchasing an additional 30,276 shares during the period. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Haleon Stock Performance

Shares of HLN opened at $10.36 on Friday. The company has a current ratio of 0.98, a quick ratio of 0.78 and a debt-to-equity ratio of 0.53. The stock has a market cap of $46.54 billion, a P/E ratio of 26.55, a PEG ratio of 2.92 and a beta of 0.25. The company has a 50-day moving average of $10.72 and a two-hundred day moving average of $10.15. Haleon has a 12-month low of $8.41 and a 12-month high of $11.42.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.